Lushang Freda Pharmaceutical Co., Ltd. Class ASSE: 600223

Report for Q1 2025

Apr 25, 2025 · Issued by Lushang Freda Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment